Contributor content
Presentation
Levosimendan therapy and mortality predictors in end-stage heart failure patients beyond advanced therapeutic options
Presentation
Mycophenolate mofetil as second-line therapy for steroid-refractory ICI-induced myocarditis
Presentation
Presentation
Hyperkalemia consequences on the probability of interrupting or lowering renin-angiotensin-aldosterone system inhibitors and risk of hospitalization in patients with chronic cardiovascular conditions
Presentation
Influence of multi-morbidity in the effectiveness of transitional-care heart failure programmes: a population-based study with longitudinal real-world data in 77,554 patients.
Presentation
Implications of levels of hyperkalemia in the risk of renin-angiotensin-aldosterone system inhibitors interruption/down-titration and mortality in patients with chronic cardiovascular conditions
Presentation
Management of renin-angiotensin-aldosterone system inhibitors in patients with chronic cardiovascular conditions and its association with clinical outcomes
Presentation
Implications of hyperkalemia in the management of renin-angiotensin-aldosterone system inhibitors in patients with chronic cardiovascular conditions and its association with clinical outcomes
Presentation
36,269 patients with chronic cardiovascular, metabolic and renal conditions: impact on clinical outcomes, medical resource use and health-related costs of deranged serum potassium levels
Presentation
